SLC6A4 and brain ischemia: We thus aimed at evaluating TSK axis markers in blood and urine, such as, for the first time, platelet SERT and 5-HT2AR, during the hyperacute phase (<4.5 h) of brain ischemia, as well as with repeated measurements at day 1 (D1) and 3 months (M3).